A and IMP Related Headlines

Go Back

Aug 25, 2026 02:25AM Implantica to host Capital Markets Day in Stockholm on September 9
Aug 21, 2026 02:24AM Implantica publishes Interim Report January - June 2026 (Q2)
Aug 20, 2026 11:32PM FDA clears Implantica's RefluxStop implant for U.S. market
Aug 20, 2026 11:31PM Implantica receives FDA approval for RefluxStop® - Opening the U.S. market
Aug 14, 2026 04:20AM Implantica presents the second quarter (Q2 2026) on August 21 at 15:00 CEST

A and IMP Related Press Releases

Go Back

Aug 25, 2026 02:25AM Implantica to host Capital Markets Day in Stockholm on September 9
Aug 21, 2026 02:24AM Implantica publishes Interim Report January - June 2026 (Q2)
Aug 20, 2026 11:31PM Implantica receives FDA approval for RefluxStop® - Opening the U.S. market
Aug 14, 2026 04:20AM Implantica presents the second quarter (Q2 2026) on August 21 at 15:00 CEST

A and IMP Related SEC Filings

Go Back